overall , 90.6 % ( 48 of 53 ) of the patients were successfully treated with moxalactam -- 86.2 % ( 25 of 29 ) and 95.8 % ( 23 of 24 ) of the patients with endometritis and pelvic inflammatory disease , respectively .
C0014179
endometritis
C0242172
pelvic